NMC.L Regulatory News (NMC)

London, 22 July 2016: NMC Health plc (LSE:NMC) ('NMC'), the leading integrated private healthcare provider operating across the United Arab Emirates and one of the top global providers of fertility treatments through its Spanish subsidiary Clinica Eugin, announces that it received notification on 21 July 2016 from Mr Mark Tompkins, Chairman of the Company, that on 20 July 2016, the following transactions changed the nature of his interest over NMC shares:

Notes:

(1) The shares were sold from an ISA account held by Mr Tompkins' wife

(2) The shares purchased were acquired by a family trust of which Mr Tompkins is a potential beneficiary.

As a result of these transactions, Mr Tompkins' interest in the shares of the Company remains unchanged at 25,083 shares, representing 0.01% of the current issued share capital of the Company, including Mrs Sarah Tompkins' direct interest in the shares of the Company of 2,983 shares, representing 0.002% of the current issued share capital of the Company, and 13,000 shares, representing 0.007% of the current issued share capital of the Company, owned by a family trust of which Mr Tompkins is a potential beneficiary.

Contacts

Investors

NMC

Simon Watkins, Group Company Secretary +44 (0)20 3205 7313

Media:

FTI Consulting, London

Matthew Cole +44 (0)20 3727 1101

FTI Consulting, Gulf

Shane Dolan +971 (0)4 437 2100